Clinical and Pharmacological Study With 2B3-101 in Patients With Breast Cancer and Leptomeningeal Metastases
Phase of Trial: Phase II
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Doxorubicin liposomal (Primary)
- Indications Breast cancer; Meningeal carcinomatosis
- Focus Adverse reactions; Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 28 Oct 2013 Planned End Date changed from 1 Apr 2014 to 1 Oct 2014 as reported by ClinicalTrials.gov.
- 01 Oct 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.